All Stories

  1. Determination of Effective Prophylactic Responses of Truncated Flagellin Protein as a Vaccine Candidate Against Uropathogenic Escherichia coli
  2. Inhibition of the blaOXA-48 gene expression in Klebsiella pneumoniae by a plasmid carrying CRISPRi-Cas9 system
  3. Sequence-subtype association of multi-drug-resistant diarrheagenic Escherichia coli
  4. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies
  5. Circulating LncRNAs landscape as potential biomarkers in breast cancer
  6. Emergence of K1 ST23 and K2 ST65 hypervirulent klebsiella pneumoniae as true pathogens with specific virulence genes in cryptogenic pyogenic liver abscesses Shiraz Iran
  7. Metagemonic analysis of bacterial genetic diversity in blood samples of Iranian healthy women
  8. Bacterial DNA Detection in the Blood of Healthy Subjects
  9. Quantitative CK19 biomarker detection in breast cancer cell lines
  10. Protein kinase signaling by Shiga Toxin subunits
  11. Circulating LncRNAs Landscape as Potential Biomarkers in Breast Cancer
  12. Characterization of antimicrobial susceptibility, extended-spectrum β-lactamase genes and phylogenetic groups of Shigatoxin producing Escherichia coli isolated from patients with diarrhea in Iran
  13. LncRNAs AK058003 and MVIH Overexpression in the Blood Samples of Iranian Breast Cancer Patients
  14. Extraction and Isolation of Antioxidant-Antibacterial Compounds From Lactobacillus casei Strain K1C by Thin-Layer Chromatography
  15. Protective multi-epitope candidate vaccine for urinary tract infection
  16. In Silico Design of a Poly-epitope Vaccine for Urinary Tract Infection Based on Conserved Antigens by Modern Vaccinology
  17. Computational evaluation of modified peptides from human neutrophil peptide 1 (HNP-1)
  18. Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm
  19. <p>A Synthetic Peptide 2Abz<sup>23</sup>S<sup>29</sup> Reduces Bacterial Titer and Induces Pro-Inflammatory Cytokines in a Murine Model of Urinary Tract Infection</p>
  20. Comparing blood versus tissue-based biomarkers expression in breast cancer patients
  21. Comparative Study of Blood, Tissue and Serum Levels of Carcinoembryonic Antigen (CEA) Detection in Breast Cancer
  22. Effect of nontypeable Haemophilus influenzae protein E (PE) as a microbial adjuvant on the amount of antibody against PRP of Haemophilus influenzae type b (Hib) in BALB/c mice
  23. Anti-tumor activity of Escherichia coli Shiga toxin A subunit delivered by SF9 insect cells
  24. Transposons: the agents of antibiotic resistance in bacteria
  25. Truncated D Protein as a New Vaccine Candidate Against Nontypeable Haemophilus influenza
  26. Modulation of Molecular Biomarker Expression in Response to Chemotherapy in Invasive Ductal Carcinoma
  27. High Yield Expression and Modified Purification of Novel Recombinant Truncated Protein FimH.MrpH against Urinary Tract Infections by Escherichia coli and Proteus mirabilis
  28. In silico design, cloning, expression and immunologic evaluation of ED fusion protein of NT H. influenza e
  29. DNA aptamer identification and characterization for E. coli O157 detection using cell based SELEX method
  30. Expression, Purification and Functional Assessment of Smallest Isoform of Human Interleukin-24 in Escherichia coli
  31. sIL-24 peptide, a human interleukin-24 isoform, induces mitochondrial-mediated apoptosis in human cancer cells
  32. In vitro study of antioxidant and antibacterial activities of Lactobacillus probiotic spp.
  33. In silico analysis of Shiga toxins (Stxs) to identify new potential vaccine targets for Shiga toxin-producing Escherichia coli
  34. An association study between CHEK2 gene mutations and susceptibility to breast cancer
  35. Designing novel construction for cell surface display of protein E on Escherichia coli using non-classical pathway based on Lpp-OmpA
  36. Evaluation of the immunogenic property of NT H. influenzae protein D with Neisseria meningitidis OMV in BALB/c
  37. Assessment of Cytokeratin-19 Gene Expression in Peripheral Blood of Breast Cancer Patients and Breast Cancer Cell Lines
  38. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors
  39. Comparative Effect of Recombinant Shiga Toxin in Induction of Pro- and Anti-Apoptotic Markers and Inflammatory Cytokines in Epithelial and Monocytic Cells
  40. Phenotypic and Genotypic Characterization of Enteroaggregative Escherichia coli Strains Isolated From Diarrheic Children in Iran
  41. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice
  42. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis
  43. Genotypic and Phenotypic Comparison of Enteroaggregative Escherichia coli Isolates from HIV-Positive and Non-HIV Diarrheal Samples
  44. Relationship between Preoperative Serum CA15-3 and CEA Levels and Clinicopathological Parameters in Breast Cancer
  45. Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli
  46. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice
  47. Molecular Markers in Peripheral Blood of Iranian Women with Breast Cancer
  48. Analyzing of expression of novel polypeptide complexes consisting of Shiga toxin B subunit and Adherence Fimbriae of Escherichia coli based on in silico modeling
  49. Attempts to Express the A1-GMCSF Immunotoxin in the Baculovirus Expression Vector System
  50. Comparison of multiplex PCR with serogrouping and PCR-RFLP of fliC gene for the detection of enteropathogenic Escherichia coli (EPEC)
  51. Assessment of immune response of the B subunit of Shiga toxin fused to AAF adhesin of Enteroaggregative Escherichia coli
  52. Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA/DNA, Protein/Protein, and DNA/Protein) in mice
  53. A recombinant hybrid peptide composed of AAF adhesin of enteroaggregative Escherichia coli and Shiga toxin B subunit elicits protective immune response in mice
  54. Study on induction of apoptosis on HeLa and Vero cells by recombinant shiga toxin and its subunits
  55. Molecular profile and genetic diversity of cytolethal distending toxin (CDT)-producing Escherichia coli isolates from diarrheal patients
  56. N-Terminus Leader Sequence of Shiga Toxin (Stx) 1 Is Essential for Production of Active Recombinant Protein in E. coli
  57. Comparison of polymerase chain reaction systems for detection of different cdt genes in Escherichia coli strains
  58. Selective cytotoxicity of recombinant STXA1-GM-CSF protein in hematopoetic cancer cells
  59. Detection of the cytolethal distending toxin locus cdtB among diarrheagenic Escherichia coli isolates from humans in Iran